Cargando…

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS

BACKGROUND/AIMS: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, adrenal hyperactivity and decreased mental health. We aimed to investigate the changes in adrenal activity, metabolic status and mental health in PCOS during treatment with escitalopram or placebo. METHODS: Fort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glintborg, Dorte, Altinok, Magda Lambaa, Ravn, Pernille, Stage, Kurt Bjerregaard, Højlund, Kurt, Andersen, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861369/ https://www.ncbi.nlm.nih.gov/pubmed/29472241 http://dx.doi.org/10.1530/EC-18-0077

Ejemplares similares

Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
por: Ravn, Pernille, et al.
Publicado: (2022)

Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
por: Glintborg, Dorte, et al.
Publicado: (2022)

Higher blood pressure in normal weight women with PCOS compared to controls
por: Mellembakken, Jan Roar, et al.
Publicado: (2021)

Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)
por: Eriksen, Mette B., et al.
Publicado: (2013)

Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
por: Eriksen, Mette, et al.
Publicado: (2010)

Testosterone therapy increases the anticoagulant potential in men with opioid-induced hypogonadism: a randomized, placebo-controlled study
por: Bøgehave, Mette, et al.
Publicado: (2023)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
por: Skov, Vibe, et al.
Publicado: (2008)

Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients – A Randomized Placebo-Controlled Trial
por: Knorr, Ulla, et al.
Publicado: (2011)

Oral and intravenous pharmacokinetics of metformin with and without oral codeine intake in healthy subjects: A cross‐over study
por: Kuhlmann, Ida, et al.
Publicado: (2021)

Long-Term Metabolic Outcomes after Gestational Diabetes Mellitus (GDM): Results from the Odense GDM Follow-Up Study (OGFUS)
por: Jacobsen, Kristine Hovde, et al.
Publicado: (2022)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

Different Endocrine Effects of an Evening Dose of Amitriptyline, Escitalopram, and Placebo in Healthy Participants
por: Frase, Lukas, et al.
Publicado: (2018)

Protocol for Escitalopram and Language Intervention for Subacute Aphasia (ELISA): A randomized, double blind, placebo-controlled trial
por: Stockbridge, Melissa D., et al.
Publicado: (2021)

Non-Classical Congenital Adrenal Hyperplasia-Causing Alleles in Adolescent Girls with PCOS and in Risk Group for PCOS Development
por: Lidaka, Lasma, et al.
Publicado: (2021)

Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study
por: Grindheim, Sindre, et al.
Publicado: (2022)

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
por: Ruhwald, Morten, et al.
Publicado: (2009)

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2018)

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
por: Glintborg, Dorte, et al.
Publicado: (2019)

Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome—A National Cohort Study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
por: Mortensen, Christina, et al.
Publicado: (2022)

Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy
por: Botha, Jaco, et al.
Publicado: (2017)

Recurrent autoimmune hypophysitis treated with rituximab: a case report
por: Kruse, Maria, et al.
Publicado: (2021)

Maternal Testosterone Concentrations in Third Trimester and Offspring Handgrip Strength at 5 Years: Odense Child Cohort
por: Dybdahl, Malene, et al.
Publicado: (2022)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial
por: Knorr, Ulla, et al.
Publicado: (2012)

Clinical Manifest X-Linked Recessive Adrenoleukodystrophy in a Female
por: Jack, Gyda Hlin Skuladottir, et al.
Publicado: (2013)

Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS
por: Paschou, Stavroula A, et al.
Publicado: (2017)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
por: Hansen, Baiba Hedegaard, et al.
Publicado: (2009)

Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
por: Liao, Baoying, et al.
Publicado: (2021)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans
por: Vanicek, Thomas, et al.
Publicado: (2022)

Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine
por: Frederiksen, Trine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0f5m0bqb30ka1tqg73r0537jb